NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on November 10, 2022.
| Conference Call | ||
| Thursday, November 10, 2022 at 4:30 PM ET | ||
| Domestic: | 888-506-0062 | |
| International: | 973-528-0011 | |
| Conference ID: | 393244 | |
| Webcast: | https://www.webcaster4.com/Webcast/Page/2879/46603 | |
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous…
WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous…
Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals HOUSTON, TEXAS / ACCESS Newswire…
Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals HOUSTON, TEXAS / ACCESS Newswire…
$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing…
$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing…